TreeWAS – Variant ID: rs11581062

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
S09.9 Unspecified injury of head	0.000	0.933	0.067
C18.3 Hepatic flexure	0.038	0.962	0.000
C18 Malignant neoplasm of colon	0.038	0.962	0.000
C18.7 Sigmoid colon	0.038	0.962	0.000
C18.2 Ascending colon	0.037	0.963	0.000
C18.6 Descending colon	0.035	0.965	0.000
C18.1 Appendix	0.033	0.967	0.000
S09 Other and unspecified injuries of head	0.000	0.973	0.027
C18.8 Overlapping lesion of colon	0.027	0.973	0.000
C18.5 Splenic flexure	0.026	0.974	0.000
C18.9 Colon, unspecified	0.024	0.976	0.000
S09.0 Injury of blood vessels of head, not elsewhere classified	0.000	0.977	0.023
S09.7 Multiple injuries of head	0.000	0.980	0.020
S09.2 Traumatic rupture of ear drum	0.000	0.980	0.020
S09.1 Injury of muscle and tendon of head	0.000	0.980	0.020
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.019	0.981	0.000
M19.01 Primary arthrosis of other joints (Shoulder region)	0.017	0.983	0.000
C18.0 Caecum	0.016	0.984	0.000
S09.8 Other specified injuries of head	0.000	0.985	0.014
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.012	0.988	0.000
C18.4 Transverse colon	0.011	0.989	0.000
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.011	0.989	0.000
Y45.0 Opioids and related analgesics	0.011	0.989	0.000
Y45.4 Antirheumatics	0.010	0.990	0.000
Y45.5 4-Aminophenol derivatives	0.009	0.991	0.000
H90 Conductive and sensorineural hearing loss	0.009	0.991	0.000
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.009	0.991	0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.008	0.992	0.000
Y45.8 Other analgesics and antipyretics	0.007	0.992	0.000
H90.0 Conductive hearing loss, bilateral	0.008	0.992	0.000
Y45.2 Propionic acid derivatives	0.007	0.993	0.000
H90.2 Conductive hearing loss, unspecified	0.007	0.993	0.000
Y45.1 Salicylates	0.007	0.993	0.000
H90.5 Sensorineural hearing loss, unspecified	0.007	0.993	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.006	0.993	0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.007	0.993	0.000
Z86.5 Personal history of other mental and behavioural disorders	0.007	0.993	0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.005	0.995	0.000
E04.2 Non-toxic multinodular goitre	0.005	0.995	0.000
J40 Bronchitis, not specified as acute or chronic	0.005	0.995	0.000
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)	0.005	0.995	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.005	0.995	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.005	0.995	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
R94.3 Abnormal results of cardiovascular function studies	0.000	0.996	0.004
Y47.1 Benzodiazepines	0.004	0.996	0.000
J45.0 Predominantly allergic asthma	0.004	0.996	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y52 Agents primarily affecting the cardiovascular system	0.004	0.996	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.004	0.996	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
D35.0 Adrenal gland	0.004	0.996	0.000
Y53.6 Antidiarrhoeal drugs	0.004	0.996	0.000
Y54.3 Benzothiadiazine derivatives	0.004	0.996	0.000
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)	0.004	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.004	0.996	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.004	0.996	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
G61.0 Guillain-Barre syndrome	0.000	0.996	0.004
Y57 Other and unspecified drugs and medicaments	0.004	0.996	0.000
Y53.4 Other laxatives	0.004	0.996	0.000
M84.1 Nonunion of fracture [pseudarthrosis]	0.004	0.996	0.000
Y52.1 Calcium-channel blockers	0.004	0.996	0.000
Y57.5 X-ray contrast media	0.003	0.996	0.000
D39.1 Ovary	0.000	0.996	0.003
H90-H95 Other disorders of ear	0.004	0.996	0.000
Y54.7 Agents affecting calcification	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.997	0.000
Y47.4 Bromine compounds	0.003	0.997	0.000
Y47.3 Paraldehyde	0.003	0.997	0.000
Y47.2 Chloral derivatives	0.003	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.000	0.997	0.003
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
O20.9 Haemorrhage in early pregnancy, unspecified	0.003	0.997	0.000
H90.3 Sensorineural hearing loss, bilateral	0.003	0.997	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
Y51.0 Anticholinesterase agents	0.003	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
H93.9 Disorder of ear, unspecified	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
Y46.2 Hydantoin derivatives	0.003	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.003	0.997	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
E04 Other non-toxic goitre	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
Y54.8 Agents affecting uric acid metabolism	0.003	0.997	0.000
E04.9 Non-toxic goitre, unspecified	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.003	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.997	0.000
Y54.0 Mineralocorticoids	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
M84.14 Nonunion of fracture [pseudarthrosis] (Hand)	0.003	0.997	0.000
S20.8 Superficial injuries of other and unspecified parts of thorax	0.003	0.997	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
O63.0 Prolonged first stage (of labour)	0.003	0.997	0.000
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
Y57.8 Other drugs and medicaments	0.003	0.997	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.003	0.997	0.000
Y56.8 Other topical agents	0.003	0.997	0.000
Y56.7 Dental drugs, topically applied	0.003	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
Y56.2 Local astringents and local detergents	0.003	0.997	0.000
Y56.1 Antipruritics	0.003	0.997	0.000
M84.18 Nonunion of fracture [pseudarthrosis] (Other)	0.003	0.997	0.000
Y50.9 Central nervous system stimulant, unspecified	0.003	0.997	0.000
Y50.8 Other central nervous system stimulants	0.003	0.997	0.000
Y50.1 Opioid receptor antagonists	0.003	0.997	0.000
Y50.0 Analeptics	0.003	0.997	0.000
Y46.4 Iminostilbenes	0.003	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
Y55.5 Anticommon cold drugs	0.003	0.997	0.000
Y55.4 Expectorants	0.003	0.997	0.000
Y55.3 Antitussives	0.003	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
Y55.0 Oxytocic drugs	0.003	0.997	0.000
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
H93 Other disorders of ear, not elsewhere classified	0.003	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.003	0.997	0.000
M84.19 Nonunion of fracture [pseudarthrosis] (Site unspecified)	0.003	0.997	0.000
M84.10 Nonunion of fracture [pseudarthrosis] (Multiple sites)	0.003	0.997	0.000
E04.0 Non-toxic diffuse goitre	0.003	0.997	0.000
Y46.6 Other and unspecified antiepileptics	0.003	0.997	0.000
M90.78 Fracture of bone in neoplastic disease (Other)	0.003	0.997	0.000
Y57.6 Other diagnostic agents	0.003	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.003	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.003	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.003	0.997	0.000
Y58.5 Diphtheria vaccine	0.003	0.997	0.000
Y58.4 Tetanus vaccine	0.003	0.997	0.000
Y58.3 Plague vaccine	0.003	0.997	0.000
Y58.2 Cholera vaccine	0.003	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.003	0.997	0.000
H94 Other disorders of ear in diseases classified elsewhere	0.003	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.003	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.003	0.997	0.000
Y59.2 Protozoal vaccines	0.003	0.997	0.000
Y59.1 Rickettsial vaccines	0.003	0.997	0.000
Y59.0 Viral vaccines	0.003	0.997	0.000
D35.1 Parathyroid gland	0.003	0.997	0.000
J43.2 Centrilobular emphysema	0.003	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
O47.9 False labour, unspecified	0.003	0.997	0.000
G61.8 Other inflammatory polyneuropathies	0.000	0.997	0.003
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.997	0.000
Y41.4 Anthelminthics	0.002	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.997	0.000
Y58.0 BCG vaccine	0.002	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.997	0.001
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.003	0.997	0.000
E04.8 Other specified non-toxic goitre	0.003	0.997	0.000
Y54.5 Other diuretics	0.002	0.997	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.997	0.002
Y59.3 Immunoglobulin	0.002	0.997	0.000
J43 Emphysema	0.003	0.997	0.000
H95.9 Postprocedural disorder of ear and mastoid process, unspecified	0.002	0.997	0.000
G61 Inflammatory polyneuropathy	0.000	0.997	0.003
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.003	0.997	0.000
Y41.1 Antimycobacterial drugs	0.002	0.997	0.000
J34.1 Cyst and mucocele of nose and nasal sinus	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.002	0.997	0.000
Y48.1 Parenteral anaesthetics	0.002	0.997	0.000
Y48.0 Inhaled anaesthetics	0.002	0.997	0.000
H91 Other hearing loss	0.003	0.997	0.000
H91.8 Other specified hearing loss	0.002	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.997	0.000
Z93.5 Cystostomy status	0.003	0.997	0.000
M75.2 Bicipital tendinitis	0.002	0.997	0.000
N02.9 Unspecified	0.003	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
J43.8 Other emphysema	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
H93.3 Disorders of acoustic nerve	0.002	0.998	0.000
H93.0 Degenerative and vascular disorders of ear	0.002	0.998	0.000
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)	0.002	0.998	0.000
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.002	0.998	0.000
J43.9 Emphysema, unspecified	0.002	0.998	0.000
H95.8 Other postprocedural disorders of ear and mastoid process	0.002	0.998	0.000
T91.3 Sequelae of injury of spinal cord	0.002	0.998	0.000
M70.22 Olecranon bursitis-Upper arm	0.002	0.998	0.000
H91.1 Presbycusis	0.002	0.998	0.000
H95.1 Other disorders following mastoidectomy	0.002	0.998	0.000
H93.8 Other specified disorders of ear	0.002	0.998	0.000
T92.1 Sequelae of fracture of arm	0.002	0.998	0.000
H93.2 Other abnormal auditory perceptions	0.002	0.998	0.000
H94.8 Other specified disorders of ear in diseases classified elsewhere	0.002	0.998	0.000
H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
D35 Benign neoplasm of other and unspecified endocrine glands	0.002	0.998	0.000
H91.3 Deaf mutism, not elsewhere classified	0.002	0.998	0.000
M90.7 Fracture of bone in neoplastic disease	0.002	0.998	0.000
N50.1 Vascular disorders of male genital organs	0.002	0.998	0.000
Q43.0 Meckel's diverticulum	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
B16.9 Acute hepatitis B without delta-agent and without hepatic coma	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.001
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.001
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.001
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.001
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.001
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.001
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.001
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
G61.9 Inflammatory polyneuropathy, unspecified	0.000	0.998	0.002
S20.3 Other superficial injuries of front wall of thorax	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
J43.1 Panlobular emphysema	0.002	0.998	0.000
J43.0 MacLeod's syndrome	0.002	0.998	0.000
J45 Asthma	0.002	0.998	0.000
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)	0.002	0.998	0.000
G61.1 Serum neuropathy	0.000	0.998	0.002
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Z11.5 Special screening examination for other viral diseases	0.002	0.998	0.000
M70.2 Olecranon bursitis	0.002	0.998	0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.002	0.998	0.000
H91.0 Ototoxic hearing loss	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.001	0.998	0.001
K37 Unspecified appendicitis	0.000	0.998	0.002
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
Z84.8 Family history of other specified conditions	0.002	0.998	0.000
S20 Superficial injury of thorax	0.002	0.998	0.000
M90.71 Fracture of bone in neoplastic disease (Shoulder region)	0.002	0.998	0.000
L40.9 Psoriasis, unspecified	0.000	0.998	0.002
M90.76 Fracture of bone in neoplastic disease (Lower leg)	0.002	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
H91.2 Sudden idiopathic hearing loss	0.002	0.998	0.000
F05.8 Other delirium	0.002	0.998	0.000
M77.12 Lateral epicondylitis (Upper arm)	0.002	0.998	0.000
J45.8 Mixed asthma	0.002	0.998	0.000
L60.2 Onychogryphosis	0.002	0.998	0.000
Z11.9 Special screening examination for infectious and parasitic diseases, unspecified	0.002	0.998	0.000
M70.23 Olecranon bursitis-Forearm	0.002	0.998	0.000
S27.0 Traumatic pneumothorax	0.000	0.998	0.002
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
Z11.0 Special screening examination for intestinal infectious diseases	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.001	0.998	0.001
M90.79 Fracture of bone in neoplastic disease (Site unspecified)	0.002	0.998	0.000
M90.77 Fracture of bone in neoplastic disease (Ankle and foot)	0.002	0.998	0.000
M90.74 Fracture of bone in neoplastic disease (Hand)	0.002	0.998	0.000
M90.73 Fracture of bone in neoplastic disease (Forearm)	0.002	0.998	0.000
D35.9 Endocrine gland, unspecified	0.002	0.998	0.000
D35.8 Pluriglandular involvement	0.002	0.998	0.000
D35.7 Other specified endocrine glands	0.002	0.998	0.000
D35.6 Aortic body and other paraganglia	0.002	0.998	0.000
D35.5 Carotid body	0.002	0.998	0.000
D35.4 Pineal gland	0.002	0.998	0.000
D35.3 Craniopharyngeal duct	0.002	0.998	0.000
J40-J47 Chronic lower respiratory diseases	0.002	0.998	0.000
M90.70 Fracture of bone in neoplastic disease (Multiple sites)	0.002	0.998	0.000
Z11.4 Special screening examination for human immunodeficiency virus [HIV]	0.002	0.998	0.000
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.002	0.998	0.000
M70 Soft tissue disorders related to use, overuse and pressure	0.002	0.998	0.000
S20.1 Other and unspecified superficial injuries of breast	0.002	0.998	0.000
H92 Otalgia and effusion of ear	0.002	0.998	0.000
M70.29 Olecranon bursitis-Site unspec	0.002	0.998	0.000
M70.28 Olecranon bursitis-Other	0.002	0.998	0.000
M70.27 Olecranon bursitis-Ankle/Foot	0.002	0.998	0.000
M70.26 Olecranon bursitis-Lower Leg	0.002	0.998	0.000
M70.25 Olecranon bursitis-Pelvic/Thigh	0.002	0.998	0.000
M70.24 Olecranon bursitis-Hand	0.002	0.998	0.000
M70.21 Olecranon bursitis-Shldr region	0.002	0.998	0.000
M70.20 Olecranon bursitis-Mult sites	0.002	0.998	0.000
M71.38 Other bursal cyst (Other)	0.002	0.998	0.000
M79.99 Soft tissue disorder, unspecified (Site unspecified)	0.002	0.998	0.000
S22.50 Flail chest (closed)	0.002	0.998	0.000
E04.1 Non-toxic single thyroid nodule	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
F02.0 Dementia in Pick's disease	0.000	0.998	0.002
I98.2 Oesophageal varices in diseases classified elsewhere	0.000	0.998	0.002
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
Z11 Special screening examination for infectious and parasitic diseases	0.002	0.998	0.000
M79.96 Soft tissue disorder, unspecified (Lower leg)	0.002	0.998	0.000
M79.94 Soft tissue disorder, unspecified (Hand)	0.002	0.998	0.000
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.002
O20.8 Other haemorrhage in early pregnancy	0.002	0.998	0.000
S20.7 Multiple superficial injuries of thorax	0.002	0.998	0.000
S20.0 Contusion of breast	0.002	0.998	0.000
M79.79 Fibromyalgia (Site unspecified)	0.002	0.998	0.000
K80.8 Other cholelithiasis	0.002	0.998	0.000
M79.9 Soft tissue disorder, unspecified	0.002	0.998	0.000
D12.9 Anus and anal canal	0.002	0.998	0.000
M70.7 Other bursitis of hip	0.002	0.998	0.000
V89.9 Person injured in unspecified vehicle accident	0.002	0.998	0.000
L81.9 Disorder of pigmentation, unspecified	0.000	0.998	0.002
M70.4 Prepatellar bursitis	0.002	0.998	0.000
N50.0 Atrophy of testis	0.002	0.998	0.000
J00 Acute nasopharyngitis [common cold]	0.000	0.998	0.002
M70.6 Trochanteric bursitis	0.002	0.998	0.000
M70.3 Other bursitis of elbow	0.002	0.998	0.000
J45.1 Nonallergic asthma	0.001	0.998	0.000
N02.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
R85.9 Unspecified abnormal finding	0.002	0.998	0.000
Z82.3 Family history of stroke	0.002	0.998	0.000
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.998	0.002
M70.75 Other bursitis of hip-Pelvic/Thigh	0.001	0.998	0.000
M79.98 Soft tissue disorder, unspecified (Other)	0.002	0.998	0.000
G95.8 Other specified diseases of spinal cord	0.002	0.998	0.000
M70.9 Unspecified soft tissue disorder related to use, overuse and pressure	0.001	0.998	0.000
M70.8 Other soft tissue disorders related to use, overuse and pressure	0.001	0.998	0.000
M70.1 Bursitis of hand	0.001	0.998	0.000
M70.0 Chronic crepitant synovitis of hand and wrist	0.001	0.998	0.000
M77.1 Lateral epicondylitis	0.002	0.998	0.000
S20.4 Other superficial injuries of back wall of thorax	0.001	0.998	0.000
O20 Haemorrhage in early pregnancy	0.002	0.998	0.000
Y40 Systemic antibiotics	0.001	0.998	0.000
F50.9 Eating disorder, unspecified	0.002	0.998	0.000
L85.8 Other specified epidermal thickening	0.002	0.998	0.000
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.002	0.998	0.000
R87.5 Abnormal microbiological findings	0.002	0.998	0.000
W55.0 Home	0.000	0.998	0.002
Z11.1 Special screening examination for respiratory tuberculosis	0.001	0.998	0.000
M70.46 Prepatellar bursitis-Lower Leg	0.002	0.998	0.000
M77.02 Medial epicondylitis (Upper arm)	0.002	0.998	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.002	0.998	0.000
K70.9 Alcoholic liver disease, unspecified	0.000	0.998	0.002
M19.0 Primary arthrosis of other joints	0.002	0.998	0.000
W55.8 Other specified place	0.000	0.998	0.002
J41 Simple and mucopurulent chronic bronchitis	0.001	0.998	0.000
M70.32 Other bursitis of elbow-Upper arm	0.001	0.998	0.000
T91.8 Sequelae of other specified injuries of neck and trunk	0.002	0.998	0.000
M94.26 Chondromalacia (Lower leg)	0.000	0.998	0.001
M94.96 Disorder of cartilage, unspecified (Lower leg)	0.000	0.998	0.001
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)	0.000	0.998	0.001
S36.00 Injury of spleen (without open wound into cavity)	0.000	0.998	0.001
D75.9 Disease of blood and blood-forming organs, unspecified	0.002	0.998	0.000
K70.0 Alcoholic fatty liver	0.000	0.998	0.002
T82.1 Mechanical complication of cardiac electronic device	0.000	0.998	0.002
Y40.1 Cefalosporins and other -lactam antibiotics	0.001	0.998	0.000
Z11.3 Special screening examination for infections with a predominantly sexual mode of transmission	0.001	0.998	0.000
J46 Status asthmaticus	0.002	0.998	0.000
M70.65 Trochanteric bursitis-Pelvic/Thigh	0.002	0.998	0.000
M71.12 Other infective bursitis (Upper arm)	0.001	0.998	0.000
M90.72 Fracture of bone in neoplastic disease (Upper arm)	0.001	0.998	0.000
C25.9 Pancreas, unspecified	0.000	0.998	0.002
H44.2 Degenerative myopia	0.002	0.998	0.000
M71.3 Other bursal cyst	0.001	0.998	0.000
Z11.6 Special screening examination for other protozoal diseases and helminthiases	0.001	0.998	0.000
N02 Recurrent and persistent haematuria	0.002	0.998	0.000
M19.03 Primary arthrosis of other joints (Forearm)	0.001	0.998	0.000
M70.79 Other bursitis of hip-Site unspec	0.001	0.998	0.000
M70.78 Other bursitis of hip-Other	0.001	0.998	0.000
M70.77 Other bursitis of hip-Ankle/Foot	0.001	0.998	0.000
M70.76 Other bursitis of hip-Lower Leg	0.001	0.998	0.000
M70.74 Other bursitis of hip-Hand	0.001	0.998	0.000
M70.73 Other bursitis of hip-Forearm	0.001	0.998	0.000
M70.72 Other bursitis of hip-Upper arm	0.001	0.998	0.000
M70.71 Other bursitis of hip-Shldr region	0.001	0.998	0.000
M70.70 Other bursitis of hip-Mult sites	0.001	0.998	0.000
M79.95 Soft tissue disorder, unspecified (Pelvic region and thigh)	0.001	0.998	0.000
M79.93 Soft tissue disorder, unspecified (Forearm)	0.001	0.998	0.000
M79.92 Soft tissue disorder, unspecified (Upper arm)	0.001	0.998	0.000
M79.91 Soft tissue disorder, unspecified (Shoulder region)	0.001	0.998	0.000
M79.90 Soft tissue disorder, unspecified (Multiple sites)	0.001	0.998	0.000
H44.1 Other endophthalmitis	0.001	0.998	0.000
R83.8 Other abnormal findings	0.001	0.998	0.000
M70.49 Prepatellar bursitis-Site unspec	0.001	0.998	0.000
M70.48 Prepatellar bursitis-Other	0.001	0.998	0.000
M70.47 Prepatellar bursitis-Ankle/Foot	0.001	0.998	0.000
M70.45 Prepatellar bursitis-Pelvic/Thigh	0.001	0.998	0.000
M70.44 Prepatellar bursitis-Hand	0.001	0.998	0.000
M70.43 Prepatellar bursitis-Forearm	0.001	0.998	0.000
M70.42 Prepatellar bursitis-Upper arm	0.001	0.998	0.000
M70.41 Prepatellar bursitis-Shldr region	0.001	0.998	0.000
M70.40 Prepatellar bursitis-Mult sites	0.001	0.998	0.000
L29.9 Pruritus, unspecified	0.001	0.998	0.000
R85.7 Abnormal histological findings	0.001	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.001	0.998	0.000
R87 Abnormal findings in specimens from female genital organs	0.001	0.998	0.000
Y43 Primarily systemic agents	0.001	0.998	0.000
M70.39 Other bursitis of elbow-Site unspec	0.001	0.999	0.000
M70.38 Other bursitis of elbow-Other	0.001	0.999	0.000
M70.37 Other bursitis of elbow-Ankle/Foot	0.001	0.999	0.000
M70.36 Other bursitis of elbow-Lower Leg	0.001	0.999	0.000
M70.35 Other bursitis of elbow-Pelvic/Thigh	0.001	0.999	0.000
M70.34 Other bursitis of elbow-Hand	0.001	0.999	0.000
M70.33 Other bursitis of elbow-Forearm	0.001	0.999	0.000
M70.31 Other bursitis of elbow-Shldr region	0.001	0.999	0.000
M70.30 Other bursitis of elbow-Mult sites	0.001	0.999	0.000
M70.69 Trochanteric bursitis-Site unspec	0.001	0.999	0.000
M70.68 Trochanteric bursitis-Other	0.001	0.999	0.000
M70.67 Trochanteric bursitis-Ankle/Foot	0.001	0.999	0.000
M70.66 Trochanteric bursitis-Lower Leg	0.001	0.999	0.000
M70.64 Trochanteric bursitis-Hand	0.001	0.999	0.000
M70.63 Trochanteric bursitis-Forearm	0.001	0.999	0.000
M70.62 Trochanteric bursitis-Upper arm	0.001	0.999	0.000
M70.61 Trochanteric bursitis-Shldr region	0.001	0.999	0.000
M70.60 Trochanteric bursitis-Mult sites	0.001	0.999	0.000
M90.61 Osteitis deformans in neoplastic disease (Shoulder region)	0.001	0.999	0.000
B15.9 Hepatitis A without hepatic coma	0.001	0.999	0.000
H92.1 Otorrhoea	0.001	0.999	0.000
Y44.2 Anticoagulants	0.001	0.999	0.000
M19.27 Other secondary arthrosis (Ankle and foot)	0.001	0.999	0.000
H92.2 Otorrhagia	0.001	0.999	0.000
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.000	0.999	0.001
M70.5 Other bursitis of knee	0.001	0.999	0.000
Z11.8 Special screening examination for other infectious and parasitic diseases	0.001	0.999	0.000
S06.00 Concussion (without open intracranial wound)	0.000	0.999	0.001
D75.0 Familial erythrocytosis	0.001	0.999	0.000
M71.1 Other infective bursitis	0.001	0.999	0.000
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.001	0.999	0.000
M70.09 Chronic crepitant synovitis of hand and wrist-Site unspec	0.001	0.999	0.000
M70.08 Chronic crepitant synovitis of hand and wrist-Other	0.001	0.999	0.000
M70.07 Chronic crepitant synovitis of hand and wrist-Ankle/Foot	0.001	0.999	0.000
M70.06 Chronic crepitant synovitis of hand and wrist-Lower Leg	0.001	0.999	0.000
M70.05 Chronic crepitant synovitis of hand and wrist-Pelvic/Thigh	0.001	0.999	0.000
M70.04 Chronic crepitant synovitis of hand and wrist (Hand)	0.001	0.999	0.000
M70.03 Chronic crepitant synovitis of hand and wrist (Forearm)	0.001	0.999	0.000
M70.02 Chronic crepitant synovitis of hand and wrist-Upper arm	0.001	0.999	0.000
M70.01 Chronic crepitant synovitis of hand and wrist-Shldr region	0.001	0.999	0.000
M70.00 Chronic crepitant synovitis of hand and wrist (Multiple sites)	0.001	0.999	0.000
M70.19 Bursitis of hand-Site unspec	0.001	0.999	0.000
M70.18 Bursitis of hand-Other	0.001	0.999	0.000
M70.17 Bursitis of hand-Ankle/Foot	0.001	0.999	0.000
M70.16 Bursitis of hand-Lower Leg	0.001	0.999	0.000
M70.15 Bursitis of hand-Pelvic/Thigh	0.001	0.999	0.000
M70.14 Bursitis of hand-Hand	0.001	0.999	0.000
M70.13 Bursitis of hand-Forearm	0.001	0.999	0.000
M70.12 Bursitis of hand-Upper arm	0.001	0.999	0.000
M70.11 Bursitis of hand-Shldr region	0.001	0.999	0.000
M70.10 Bursitis of hand-Mult sites	0.001	0.999	0.000
M70.89 Other soft tissue disorders related to use, overuse and pressure (Site unspecified)	0.001	0.999	0.000
M70.88 Other soft tissue disorders related to use, overuse and pressure (Other)	0.001	0.999	0.000
M70.87 Other soft tissue disorders related to use, overuse and pressure (Ankle and foot)	0.001	0.999	0.000
M70.86 Other soft tissue disorders related to use, overuse and pressure (Lower leg)	0.001	0.999	0.000
M70.85 Other soft tissue disorders related to use, overuse and pressure (Pelvic region and thigh)	0.001	0.999	0.000
M70.84 Other soft tissue disorders related to use, overuse and pressure (Hand)	0.001	0.999	0.000
M70.83 Other soft tissue disorders related to use, overuse and pressure (Forearm)	0.001	0.999	0.000
M70.82 Other soft tissue disorders related to use, overuse and pressure (Upper arm)	0.001	0.999	0.000
M70.81 Other soft tissue disorders related to use, overuse and pressure (Shoulder region)	0.001	0.999	0.000
M70.80 Other soft tissue disorders related to use, overuse and pressure (Multiple sites)	0.001	0.999	0.000
M70.99 Unspecified soft tissue disorder related to use, overuse and pressure (Site unspecified)	0.001	0.999	0.000
M70.98 Unspecified soft tissue disorder related to use, overuse and pressure (Other)	0.001	0.999	0.000
M70.97 Unspecified soft tissue disorder related to use, overuse and pressure (Ankle and foot)	0.001	0.999	0.000
M70.96 Unspecified soft tissue disorder related to use, overuse and pressure (Lower leg)	0.001	0.999	0.000
M70.95 Unspecified soft tissue disorder related to use, overuse and pressure (Pelvic region and thigh)	0.001	0.999	0.000
M70.94 Unspecified soft tissue disorder related to use, overuse and pressure (Hand)	0.001	0.999	0.000
M70.93 Unspecified soft tissue disorder related to use, overuse and pressure (Forearm)	0.001	0.999	0.000
M70.92 Unspecified soft tissue disorder related to use, overuse and pressure (Upper arm)	0.001	0.999	0.000
M70.91 Unspecified soft tissue disorder related to use, overuse and pressure (Shoulder region)	0.001	0.999	0.000
M70.90 Unspecified soft tissue disorder related to use, overuse and pressure (Multiple sites)	0.001	0.999	0.000
M77.19 Lateral epicondylitis (Site unspecified)	0.001	0.999	0.000
M77.18 Lateral epicondylitis-Other	0.001	0.999	0.000
M77.17 Lateral epicondylitis-Ankle/Foot	0.001	0.999	0.000
M77.16 Lateral epicondylitis (Lower leg)	0.001	0.999	0.000
M77.15 Lateral epicondylitis (Pelvic region and thigh)	0.001	0.999	0.000
M77.14 Lateral epicondylitis-Hand	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations